Full Text View
Tabular View
No Study Results Posted
Related Studies
Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A
This study has been terminated.
Study NCT00621673   Information provided by Bayer
First Received: February 12, 2008   Last Updated: June 29, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hemophilia A
More general conditions related to this trial
Blood Coagulation Disorders
Blood Coagulation Disorders, Inherited
Coagulation Protein Disorders
Genetic Diseases, Inborn
Hematologic Diseases
Hemorrhagic Disorders
Interventions listed in this trial
Kogenate (BAY 14-2222)
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services